| 107.65 -3.94 (-3.53%) | 06-09 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 137.3 |
1-year : | 147.16 |
| Resists | First : | 117.55 |
Second : | 126 |
| Pivot price | 116.99  |
|||
| Supports | First : | 103.88 |
Second : | 86.43 |
| MAs | MA(5) : | 115.11 |
MA(20) : | 115.58 |
| MA(100) : | 100.77 |
MA(250) : | 88.79 |
|
| MACD | MACD : | 2.6 |
Signal : | 4.3 |
| %K %D | K(14,3) : | 28.9 |
D(3) : | 49.1 |
| RSI | RSI(14): 42.8 |
|||
| 52-week | High : | 126 | Low : | 55.33 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CNRG ] has closed above bottom band by 11.3%. Bollinger Bands are 100.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 10 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 113.7 - 114.63 | 114.63 - 115.25 |
| Low: | 102.22 - 103.18 | 103.18 - 103.82 |
| Close: | 106.36 - 107.89 | 107.89 - 108.91 |
This ETF is designed to replicate the total return performance of the S&P Kensho Clean Power Index, excluding fees and operating expenses. The benchmark index it follows leverages artificial intelligence and a data-driven weighting strategy to pinpoint companies whose products and services are driving innovation in the sustainable energy industry, including renewable sources like solar, wind, geothermal, and hydroelectric power. It seeks to provide investors with a potentially effective way to pursue long-term capital growth by investing in firms that are integral to the global shift towards a power supply with reduced emissions.
Fri, 05 Jun 2026
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Yahoo Finance
Fri, 05 Jun 2026
Should State Street SPDR Portfolio S&P 500 Growth ETF (SPYG) be on your investing radar? - MSN
Thu, 04 Jun 2026
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? - The Motley Fool
Wed, 03 Jun 2026
Should you invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - MSN
Tue, 02 Jun 2026
Is State Street SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now? - Yahoo Finance
Fri, 29 May 2026
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|